Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 34 of 34 entries
Sorted by: Best Match Show Resources per page
Correction: TLR7 trafficking and signaling in B cells is regulated by the MHCII-associated invariant chain.

Journal of cell science

Tohme M, Maisonneuve L, Achour K, Dussiot M, Maschalidi S, Manoury B.
PMID: 34713886
J Cell Sci. 2021 Oct 15;134(20). doi: 10.1242/jcs.259376. Epub 2021 Oct 29.

No abstract available.

Cite
Tohme M, Maisonneuve L, Achour K, et al. Correction: TLR7 trafficking and signaling in B cells is regulated by the MHCII-associated invariant chain. J Cell Sci. 2021;134(20)doi: 10.1242/jcs.259376.
Tohme, M., Maisonneuve, L., Achour, K., Dussiot, M., Maschalidi, S., & Manoury, B. (2021). Correction: TLR7 trafficking and signaling in B cells is regulated by the MHCII-associated invariant chain. Journal of cell science, 134(20), . https://doi.org/10.1242/jcs.259376
Tohme, Mira, et al. "Correction: TLR7 trafficking and signaling in B cells is regulated by the MHCII-associated invariant chain." Journal of cell science vol. 134,20 (2021). doi: https://doi.org/10.1242/jcs.259376
Tohme M, Maisonneuve L, Achour K, Dussiot M, Maschalidi S, Manoury B. Correction: TLR7 trafficking and signaling in B cells is regulated by the MHCII-associated invariant chain. J Cell Sci. 2021 Oct 15;134(20). doi: 10.1242/jcs.259376. Epub 2021 Oct 29. PMID: 34713886.
Copy Download .nbib Format: NLM
Molecular and cellular analyses of HLA class II-associated susceptibility to autoimmune diseases in the Japanese population.

Modern rheumatology

Nishimura Y, Ito H, Fujii S, Tabata H, Tokano Y, Chen YZ, Matsuda I, Mitsuya H, Kira J, Hashimoto H, Senju S, Matsushita S.
PMID: 24383685
Mod Rheumatol. 2001 Jun;11(2):103-12. doi: 10.3109/s101650170020.

Abstract It is well known that individuals who are positive for particular HLA class II alleles show a high risk of developing autoimmune diseases. HLA class II molecules expressed on antigen-presenting cells present antigenic peptides to CD4(+) T cells....

Cite
Nishimura Y, Ito H, Fujii S, et al. Molecular and cellular analyses of HLA class II-associated susceptibility to autoimmune diseases in the Japanese population. Mod Rheumatol. 2001;11(2):103-12doi: 10.3109/s101650170020.
Nishimura, Y., Ito, H., Fujii, S., Tabata, H., Tokano, Y., Chen, Y. Z., Matsuda, I., Mitsuya, H., Kira, J., Hashimoto, H., Senju, S., & Matsushita, S. (2001). Molecular and cellular analyses of HLA class II-associated susceptibility to autoimmune diseases in the Japanese population. Modern rheumatology, 11(2), 103-12. https://doi.org/10.3109/s101650170020
Nishimura, Y, et al. "Molecular and cellular analyses of HLA class II-associated susceptibility to autoimmune diseases in the Japanese population." Modern rheumatology vol. 11,2 (2001): 103-12. doi: https://doi.org/10.3109/s101650170020
Nishimura Y, Ito H, Fujii S, Tabata H, Tokano Y, Chen YZ, Matsuda I, Mitsuya H, Kira J, Hashimoto H, Senju S, Matsushita S. Molecular and cellular analyses of HLA class II-associated susceptibility to autoimmune diseases in the Japanese population. Mod Rheumatol. 2001 Jun;11(2):103-12. doi: 10.3109/s101650170020. PMID: 24383685.
Copy Download .nbib Format: NLM
Invariant chain--a regulator of antigen presentation.

Trends in cell biology

Teyton L, Peterson PA.
PMID: 14731527
Trends Cell Biol. 1992 Feb;2(2):52-6. doi: 10.1016/0962-8924(92)90163-h.

MHC class II molecules present internalized antigens to the immune system. They have long been known to associate with a polypeptide called the invariant chain. Recent findings have revealed that this polypeptide performs two functions. First, it prevents class...

Cite
Teyton L, Peterson PA. Invariant chain--a regulator of antigen presentation. Trends Cell Biol. 1992;2(2):52-6doi: 10.1016/0962-8924(92)90163-h.
Teyton, L., & Peterson, P. A. (1992). Invariant chain--a regulator of antigen presentation. Trends in cell biology, 2(2), 52-6. https://doi.org/10.1016/0962-8924(92)90163-h
Teyton, L, and Peterson, P A. "Invariant chain--a regulator of antigen presentation." Trends in cell biology vol. 2,2 (1992): 52-6. doi: https://doi.org/10.1016/0962-8924(92)90163-h
Teyton L, Peterson PA. Invariant chain--a regulator of antigen presentation. Trends Cell Biol. 1992 Feb;2(2):52-6. doi: 10.1016/0962-8924(92)90163-h. PMID: 14731527.
Copy Download .nbib Format: NLM
Levetiracetam Differentially Alters CD95 Expression of Neuronal Cells and the Mitochondrial Membrane Potential of Immune and Neuronal Cells in vitro.

Frontiers in neurology

Rogers SK, Shapiro LA, Tobin RP, Tow B, Zuzek A, Mukherjee S, Newell-Rogers MK.
PMID: 24600432
Front Neurol. 2014 Feb 18;5:17. doi: 10.3389/fneur.2014.00017. eCollection 2014.

Epilepsy is a neurological seizure disorder that affects over 100 million people worldwide. Levetiracetam, either alone, as monotherapy, or as adjunctive treatment, is widely used to control certain types of seizures. Despite its increasing popularity as a relatively safe...

Cite
Rogers SK, Shapiro LA, Tobin RP, et al. Levetiracetam Differentially Alters CD95 Expression of Neuronal Cells and the Mitochondrial Membrane Potential of Immune and Neuronal Cells in vitro. Front Neurol. 2014;5:17doi: 10.3389/fneur.2014.00017.
Rogers, S. K., Shapiro, L. A., Tobin, R. P., Tow, B., Zuzek, A., Mukherjee, S., & Newell-Rogers, M. K. (2014). Levetiracetam Differentially Alters CD95 Expression of Neuronal Cells and the Mitochondrial Membrane Potential of Immune and Neuronal Cells in vitro. Frontiers in neurology, 517. https://doi.org/10.3389/fneur.2014.00017
Rogers, Susannah K, et al. "Levetiracetam Differentially Alters CD95 Expression of Neuronal Cells and the Mitochondrial Membrane Potential of Immune and Neuronal Cells in vitro." Frontiers in neurology vol. 5 (2014): 17. doi: https://doi.org/10.3389/fneur.2014.00017
Rogers SK, Shapiro LA, Tobin RP, Tow B, Zuzek A, Mukherjee S, Newell-Rogers MK. Levetiracetam Differentially Alters CD95 Expression of Neuronal Cells and the Mitochondrial Membrane Potential of Immune and Neuronal Cells in vitro. Front Neurol. 2014 Feb 18;5:17. doi: 10.3389/fneur.2014.00017. eCollection 2014. PMID: 24600432; PMCID: PMC3927234.
Copy Download .nbib Format: NLM
Dataset of clinical, immunohistopathological and laboratory features of patients with MHC II deficiency suffering from enteropathy.

Data in brief

Posovszky C, Sirin M, Jacobsen E, Lorenz M, Schwarz K, Schmidt-Choudhury A, Schütz C, Hönig M, Debatin KM, Schulz A, Möller P, Barth TF.
PMID: 31516959
Data Brief. 2019 Aug 28;26:104446. doi: 10.1016/j.dib.2019.104446. eCollection 2019 Oct.

Major histocompatibility complex class II (MHC II) is essential for adaptive immune response. We recently reported on disturbed adaptive mucosal immunity due to MHC II deficiency and prolonged enteropathy. Here, we share medical history, flow cytometric analysis of blood...

Cite
Posovszky C, Sirin M, Jacobsen E, et al. Dataset of clinical, immunohistopathological and laboratory features of patients with MHC II deficiency suffering from enteropathy. Data Brief. 2019;26:104446doi: 10.1016/j.dib.2019.104446.
Posovszky, C., Sirin, M., Jacobsen, E., Lorenz, M., Schwarz, K., Schmidt-Choudhury, A., Schütz, C., Hönig, M., Debatin, K. M., Schulz, A., Möller, P., & Barth, T. F. (2019). Dataset of clinical, immunohistopathological and laboratory features of patients with MHC II deficiency suffering from enteropathy. Data in brief, 26104446. https://doi.org/10.1016/j.dib.2019.104446
Posovszky, Carsten, et al. "Dataset of clinical, immunohistopathological and laboratory features of patients with MHC II deficiency suffering from enteropathy." Data in brief vol. 26 (2019): 104446. doi: https://doi.org/10.1016/j.dib.2019.104446
Posovszky C, Sirin M, Jacobsen E, Lorenz M, Schwarz K, Schmidt-Choudhury A, Schütz C, Hönig M, Debatin KM, Schulz A, Möller P, Barth TF. Dataset of clinical, immunohistopathological and laboratory features of patients with MHC II deficiency suffering from enteropathy. Data Brief. 2019 Aug 28;26:104446. doi: 10.1016/j.dib.2019.104446. eCollection 2019 Oct. PMID: 31516959; PMCID: PMC6736774.
Copy Download .nbib Format: NLM
Aberrant Expression of and Cell Death Induction by Engagement of the MHC-II Chaperone CD74 in Anaplastic Large Cell Lymphoma (ALCL).

Cancers

Wurster KD, Costanza M, Kreher S, Glaser S, Lamprecht B, Schleussner N, Anagnostopoulos I, Hummel M, Jöhrens K, Stein H, Molina A, Diepstra A, Gillissen B, Köchert K, Siebert R, Merkel O, Kenner L, Janz M, Mathas S.
PMID: 34638496
Cancers (Basel). 2021 Oct 07;13(19). doi: 10.3390/cancers13195012.

In 50-60% of cases, systemic anaplastic large cell lymphoma (ALCL) is characterized by the t(2;5)(p23;q35) or one of its variants, considered to be causative for anaplastic lymphoma kinase (ALK)-positive (ALK

Cite
Wurster KD, Costanza M, Kreher S, et al. Aberrant Expression of and Cell Death Induction by Engagement of the MHC-II Chaperone CD74 in Anaplastic Large Cell Lymphoma (ALCL). Cancers (Basel). 2021;13(19)doi: 10.3390/cancers13195012.
Wurster, K. D., Costanza, M., Kreher, S., Glaser, S., Lamprecht, B., Schleussner, N., Anagnostopoulos, I., Hummel, M., Jöhrens, K., Stein, H., Molina, A., Diepstra, A., Gillissen, B., Köchert, K., Siebert, R., Merkel, O., Kenner, L., Janz, M., & Mathas, S. (2021). Aberrant Expression of and Cell Death Induction by Engagement of the MHC-II Chaperone CD74 in Anaplastic Large Cell Lymphoma (ALCL). Cancers, 13(19), . https://doi.org/10.3390/cancers13195012
Wurster, Kathrin D, et al. "Aberrant Expression of and Cell Death Induction by Engagement of the MHC-II Chaperone CD74 in Anaplastic Large Cell Lymphoma (ALCL)." Cancers vol. 13,19 (2021). doi: https://doi.org/10.3390/cancers13195012
Wurster KD, Costanza M, Kreher S, Glaser S, Lamprecht B, Schleussner N, Anagnostopoulos I, Hummel M, Jöhrens K, Stein H, Molina A, Diepstra A, Gillissen B, Köchert K, Siebert R, Merkel O, Kenner L, Janz M, Mathas S. Aberrant Expression of and Cell Death Induction by Engagement of the MHC-II Chaperone CD74 in Anaplastic Large Cell Lymphoma (ALCL). Cancers (Basel). 2021 Oct 07;13(19). doi: 10.3390/cancers13195012. PMID: 34638496; PMCID: PMC8507667.
Copy Download .nbib Format: NLM
HLA Class II Presentation Is Specifically Altered at Elevated Temperatures in the B-Lymphoblastic Cell Line JY.

Molecular & cellular proteomics : MCP

Demmers LC, Wu W, Heck AJR.
PMID: 33933681
Mol Cell Proteomics. 2021 Apr 29;20:100089. doi: 10.1016/j.mcpro.2021.100089. Epub 2021 Apr 29.

Human leukocyte antigen (HLA) molecules play critical roles in our adaptive immune system by signaling a cell's health status to the immune system, through presentation of small peptides. Understanding HLA biology is important because of its prominent role in...

Cite
Demmers LC, Wu W, Heck AJR. HLA Class II Presentation Is Specifically Altered at Elevated Temperatures in the B-Lymphoblastic Cell Line JY. Mol Cell Proteomics. 2021;20:100089doi: 10.1016/j.mcpro.2021.100089.
Demmers, L. C., Wu, W., & Heck, A. J. R. (2021). HLA Class II Presentation Is Specifically Altered at Elevated Temperatures in the B-Lymphoblastic Cell Line JY. Molecular & cellular proteomics : MCP, 20100089. https://doi.org/10.1016/j.mcpro.2021.100089
Demmers, Laura C, et al. "HLA Class II Presentation Is Specifically Altered at Elevated Temperatures in the B-Lymphoblastic Cell Line JY." Molecular & cellular proteomics : MCP vol. 20 (2021): 100089. doi: https://doi.org/10.1016/j.mcpro.2021.100089
Demmers LC, Wu W, Heck AJR. HLA Class II Presentation Is Specifically Altered at Elevated Temperatures in the B-Lymphoblastic Cell Line JY. Mol Cell Proteomics. 2021 Apr 29;20:100089. doi: 10.1016/j.mcpro.2021.100089. Epub 2021 Apr 29. PMID: 33933681.
Copy Download .nbib Format: NLM
HLA Class II Presentation Is Specifically Altered at Elevated Temperatures in the B-Lymphoblastic Cell Line JY.

Molecular & cellular proteomics : MCP

Demmers LC, Wu W, Heck AJR.
PMID: 33933681
Mol Cell Proteomics. 2021;20:100089. doi: 10.1016/j.mcpro.2021.100089. Epub 2021 Apr 29.

Human leukocyte antigen (HLA) molecules play critical roles in our adaptive immune system by signaling a cell's health status to the immune system, through presentation of small peptides. Understanding HLA biology is important because of its prominent role in...

Cite
Demmers LC, Wu W, Heck AJR. HLA Class II Presentation Is Specifically Altered at Elevated Temperatures in the B-Lymphoblastic Cell Line JY. Mol Cell Proteomics. 2021;20:100089doi: 10.1016/j.mcpro.2021.100089.
Demmers, L. C., Wu, W., & Heck, A. J. R. (2021). HLA Class II Presentation Is Specifically Altered at Elevated Temperatures in the B-Lymphoblastic Cell Line JY. Molecular & cellular proteomics : MCP, 20100089. https://doi.org/10.1016/j.mcpro.2021.100089
Demmers, Laura C, et al. "HLA Class II Presentation Is Specifically Altered at Elevated Temperatures in the B-Lymphoblastic Cell Line JY." Molecular & cellular proteomics : MCP vol. 20 (2021): 100089. doi: https://doi.org/10.1016/j.mcpro.2021.100089
Demmers LC, Wu W, Heck AJR. HLA Class II Presentation Is Specifically Altered at Elevated Temperatures in the B-Lymphoblastic Cell Line JY. Mol Cell Proteomics. 2021;20:100089. doi: 10.1016/j.mcpro.2021.100089. Epub 2021 Apr 29. PMID: 33933681; PMCID: PMC8724904.
Copy Download .nbib Format: NLM
The transmembrane domain and luminal C-terminal region independently support invariant chain trimerization and assembly with MHCII into nonamers.

BMC immunology

Cloutier M, Fortin JS, Thibodeau J.
PMID: 34384367
BMC Immunol. 2021 Aug 12;22(1):56. doi: 10.1186/s12865-021-00444-6.

BACKGROUND: Invariant chain (CD74, Ii) is a multifunctional protein expressed in antigen presenting cells. It assists the ER exit of various cargos and serves as a receptor for the macrophage migration inhibitory factor. The newly translated Ii chains trimerize,...

Cite
Cloutier M, Fortin JS, Thibodeau J. The transmembrane domain and luminal C-terminal region independently support invariant chain trimerization and assembly with MHCII into nonamers. BMC Immunol. 2021;22(1):56doi: 10.1186/s12865-021-00444-6.
Cloutier, M., Fortin, J. S., & Thibodeau, J. (2021). The transmembrane domain and luminal C-terminal region independently support invariant chain trimerization and assembly with MHCII into nonamers. BMC immunology, 22(1), 56. https://doi.org/10.1186/s12865-021-00444-6
Cloutier, Maryse, et al. "The transmembrane domain and luminal C-terminal region independently support invariant chain trimerization and assembly with MHCII into nonamers." BMC immunology vol. 22,1 (2021): 56. doi: https://doi.org/10.1186/s12865-021-00444-6
Cloutier M, Fortin JS, Thibodeau J. The transmembrane domain and luminal C-terminal region independently support invariant chain trimerization and assembly with MHCII into nonamers. BMC Immunol. 2021 Aug 12;22(1):56. doi: 10.1186/s12865-021-00444-6. PMID: 34384367; PMCID: PMC8362237.
Copy Download .nbib Format: NLM
HLA Class II Presentation Is Specifically Altered at Elevated Temperatures in the B-Lymphoblastic Cell Line JY.

Molecular & cellular proteomics : MCP

Demmers LC, Wu W, Heck AJR.
PMID: 33933681
Mol Cell Proteomics. 2021;20:100089. doi: 10.1016/j.mcpro.2021.100089. Epub 2021 Apr 29.

Human leukocyte antigen (HLA) molecules play critical roles in our adaptive immune system by signaling a cell's health status to the immune system, through presentation of small peptides. Understanding HLA biology is important because of its prominent role in...

Cite
Demmers LC, Wu W, Heck AJR. HLA Class II Presentation Is Specifically Altered at Elevated Temperatures in the B-Lymphoblastic Cell Line JY. Mol Cell Proteomics. 2021;20:100089doi: 10.1016/j.mcpro.2021.100089.
Demmers, L. C., Wu, W., & Heck, A. J. R. (2021). HLA Class II Presentation Is Specifically Altered at Elevated Temperatures in the B-Lymphoblastic Cell Line JY. Molecular & cellular proteomics : MCP, 20100089. https://doi.org/10.1016/j.mcpro.2021.100089
Demmers, Laura C, et al. "HLA Class II Presentation Is Specifically Altered at Elevated Temperatures in the B-Lymphoblastic Cell Line JY." Molecular & cellular proteomics : MCP vol. 20 (2021): 100089. doi: https://doi.org/10.1016/j.mcpro.2021.100089
Demmers LC, Wu W, Heck AJR. HLA Class II Presentation Is Specifically Altered at Elevated Temperatures in the B-Lymphoblastic Cell Line JY. Mol Cell Proteomics. 2021;20:100089. doi: 10.1016/j.mcpro.2021.100089. Epub 2021 Apr 29. PMID: 33933681; PMCID: PMC8724904.
Copy Download .nbib Format: NLM
Showing 25 to 34 of 34 entries